In 1997, the FDA opened the flood gates on direct-to-consumer advertising, thus allowing drugmakers to promote their products on television. DTC has raised awareness of disease and prompted consumers to talk to their doctor about often sensitive topics, but it has also aroused some controversy.

In a recent editorial, Ian Spatz, a former vice president for global health policy at Merck, says doctors feel pressured to prescribe the drugs patients request. And critics say the ads push consumer to ask their doctors for expensive branded drugs, driving up the cost of healthcare.

He suggests drugmakers collaborate on disease-focused campaigns that raise awareness of certain conditions and urge patients to talk to their doctors for treatment options. Doing so would cut companies' advertising budgets, end the ridiculous laundry list of frightening side effects mandated by the FDA, and deliver important information to patients.

While TV proved the dominant medium for DTC in the early 2000s, things might be changing, as Gregory Aston pointed out recently in a blog post for Marketing: Health. In 2010, TV investment fell 17 percent, more than twice the rate of the total category. GSK and six other major pharmaceutical companies significantly reduced their TV investment. Meanwhile, there was a growth seen print (plus 13 percent in 2010, Aston points out). He doesn't see this as a surprise, as it is a tried and tested method to getting the industry's point across.


DTC advertising

Latest Headlines

Latest Headlines

Last blast? New Amgen TV ad spotlights Neulasta delivery just months before patent expiration

Amgen is giving Neulasta its first TV advertising push in years--just months before its patent expires. But there's a case to be made for promoting the biologic this late in the game. 

Sanofi Pasteur drafts Bollywood star to talk up flu shots in India

For celebrity campaigns in the U.S., pharma often goes to Hollywood. In India, it's Bollywood--and Sanofi Pasteur is doing just that. The Sanofi vaccines venture tapped popular actor and director Farhan Akhtar to launch its latest flu immunization push in the country.

Does high TV ad rotation give patients the wrong idea about drugs?

Who carries more weight with patients: celebrities, models or real people? What one change would influential patients make to pharma's advertising? WEGO Health tried to get some answers from high-profile patients.

GSK's big, bad whooping cough vaccination campaign bares its teeth

The wolf who gobbled up Little Red Riding Hood's grandma has nothing on GlaxoSmithKline's new big bad wolf. The frightening star of a new marketing effort encouraging whooping cough vaccinations transfigures a grandmother's face while she cradles her newborn grandchild. Even GSK notes the ad may be "a bit unsettling" to some people.

Pharma TV ad study finds drug rivalries have fringe benefit

New research finds that too much pharma advertising is focused on attacking rival drugs. But those ads are still driving people to ask their doctors about conditions and treatments, and that's a positive, said Wharton business economics professor Michael Sinkinson, who recently co-authored a study measuring the impact of DTC television ads.

Hot summer ad wars: Celgene launches Otezla DTC into crowded psoriasis drug market

Celgene's Otezla is the newest entrant in what is shaping up to be a summer throwdown among psoriasis drugmakers. Not surprisingly, every company's got its own strategy.

Nuedexta maker Avanir taps actor Danny Glover to shed light on little-known neurological condition

Actors cry and laugh on command, but people who have pseudobulbar affect can't control their crying jags or laughing fits. That's the central idea of Avanir's new PBA awareness effort, starring actor Danny Glover.

AstraZeneca nabs top pharma ad award at Cannes amid slim product-specific field

AstraZeneca and its agency DigitasLBI won the top award for pharma at the Cannes' Lions Health awards, for its disease awareness campaign "Take it From a Fish" about the importance of triglycerides. It was the first time a top award was given in pharma, as last year's judges did not select a Pharma Grand Prix winner.

Brutal honesty in drug marketing? For obesity meds, it's key to avoiding the 'magic pill' trap

Dieting and exercise to lose weight is more effective when done with support--and weight-loss drugmakers have taken that to heart in marketing their treatments. But according to a recent Journal of Public Policy & Marketing article, lifestyle support isn't enough. Drugmakers may want to look to their advertising pitches, too.

Never too old to be young, Pfizer says, with new tack on Get Old campaign

Pfizer's "Get Old" campaign is going in a new direction. The drugmaker's counterintuitive--yet quite successful--aging campaign celebrates turning four with a new look and attitude built around commencing, appropriately timed to the new-graduate season. And it already has older folks taking selfies on the streets of New York.